MalarVX is a Seattle-based company that specializes in vaccine development and research for malaria. With a dedicated team and a strong corporate strategy, they aim to combat this global health challenge through innovative solutions.
Supported by an experienced management team, advisory board, and collaborators, MalarVX focuses on advancing their research and development efforts to create effective vaccines. Their commitment to scientific publications ensures the dissemination of valuable knowledge in the field.
Generated from the website